The Eurecat technology centre is using its multi-technology capabilities to address COVID-19. They include developing devices, software and hardware for data processing, expertise in artificial intelligence applied to bioinformatics, infrastructures for biotechnology trials and analysis, setting up platforms and knowledge transfer.

Over recent weeks the technology centre has been delivering its knowhow in the integrated design and development of medical devices, drawing on its expertise and experience in plastic, metal, composite and fabric materials or a combination of them and their processing to take the developed and tested product to approval and the market. Examples include testing fabrics and other materials to make medical facemasks.

In terms of medical devices and equipment, Eurecat can implement printed electronics and software in solutions especially in the Internet of Things.

Digital technologies in healthcare

In digital technologies, Eurecat shares with other organisations its extensive experience in conducting projects in infectious processes and data analysis of ICU patients at risk of infectious processes and sepsis. This includes intensive monitoring of ICU data along with clinical and epidemiological data.

It is also making its expertise available to the medical and healthcare sector to develop applications and platforms for managing and analysing medical data and applying statistical and bioinformatics techniques, machine learning and artificial intelligence across the entire data lifecycle.

Eurecat has additionally provided its data analysis capabilities as coordinator of the CIDAI (Centre for Innovation in Data Tech and Artificial Intelligence) along with the capabilities of its proprietary computing cluster, which allows it to tackle complex and computationally-intensive big data and AI projects as well as data analytics for establishing mobility patterns.

In telemedicine, Eurecat has developed a range of tools for remotely monitoring patients so that their progress can be closely tracked.

Biotech capabilities

The Centre for Omic Sciences is a joint unit with Rovira i Virgili University which has technology and experience in searching for biomarkers and integrating the data derived in a range of omic technologies.

Meanwhile, Eurecat’s Nutrition and Health Unit has the reagents and infrastructure needed to conduct the microbial cleanliness trials required in testing to validate fabric facemasks for sanitary use

Project integration for utmost flexibility

Eurecat is also promoting integration of the projects it is engaged in which provide essential medical supplies. The intention is to move towards standardisation which enables a quick response to requests and producing the largest number of units possible.

Talent training

The technology centre additionally delivers advice about good practices and telecommuting along with online training content in a range of technological fields.